ANTHRACYCLINE CARDIOTOXICITY: THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXRAZOXANE AND ITS OPEN RING METABOLITE

被引：0
|
作者：
Jirkovska-Vavrova, A. [1 ]
Jirkovsky, E. [2 ]
Stariat, J. [1 ]
Jansova, H. [1 ]
Roh, J. [1 ]
Lencova-Popelova, O. [2 ]
Kovarikova, P. [1 ]
Sterba, M. [2 ]
Simunek, T. [1 ]
机构：
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic
来源：
HEART | 2014年 / 100卷
关键词：
D O I：
10.1136/heartjnl-2014-306916.20
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
020
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo
    Jirkovska-Vavrova, Anna
    Roh, Jaroslav
    Lencova-Popelova, Olga
    Jirkovsky, Eduard
    Hruskova, Katerina
    Potuckova-Mackova, Eliska
    Jansova, Hana
    Haskova, Pavlina
    Martinkova, Pavla
    Eisner, Tomas
    Kratochvil, Marek
    Sus, Jan
    Machacek, Miloslav
    Vostatkova-Tichotova, Lucie
    Gersl, Vladimir
    Kalinowski, Danuta S.
    Muller, Mark T.
    Richardson, Des R.
    Vavrova, Katerina
    Sterba, Martin
    Simunek, Tomas
    TOXICOLOGY RESEARCH, 2015, 4 (04) : 1098 - 1114
  • [2] Dexrazoxane use advocated to prevent anthracycline cardiotoxicity
    Reactions Weekly, 1999, 775 (1) : 2 - 2
  • [3] Dexrazoxane cost effective in preventing anthracycline cardiotoxicity
    Reactions Weekly, 2020, 1791 (1) : 8 - 8
  • [4] Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
    Choi, Hyoung Soo
    Park, Eun Sil
    Kang, Hyoung Jin
    Shin, Hee Young
    Noh, Chung Il
    Yun, Yong Soo
    Ahn, Hyo Seop
    Choi, Jung Yun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (09) : 1336 - 1342
  • [5] DEXRAZOXANE FOR PROTECTION OF ANTHRACYCLINE CARDIOTOXICITY IN CHILDREN WITH SOLID TUMORS
    Choi, Hyoungsoo
    Kang, Hyoung Jin
    Shin, Hee Young
    Seo, Jong Jin
    Ahn, Hyo Seop
    Choi, Jung Yon
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 735 - 736
  • [6] Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
    Macedo, Ariane V. S.
    Hajjar, Ludhmila A.
    Lyon, Alexander R.
    Nascimento, Bruno R.
    Putzu, Alessandro
    Rossi, Lorenzo
    Costa, Rafael B.
    Landoni, Giovanni
    Nogueira-Rodrigues, Angelica
    Ribeiro, Antonio L. P.
    JACC: CARDIOONCOLOGY, 2019, 1 (01): : 68 - 79
  • [7] Anthracycline cardiotoxicity prevention by dexrazoxane: Analysis and implications.
    Hellmann, K
    CLINICAL CANCER RESEARCH, 2000, 6 : 4538S - 4538S
  • [8] PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTHRACYCLINE ANTIBIOTICS
    JOHNSON, RK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1977, 174 (SEP): : 68 - 68
  • [9] Ameliorating anthracycline cardiotoxicity in children with cancer: Clinical trials with dexrazoxane
    Wexler, LH
    SEMINARS IN ONCOLOGY, 1998, 25 (04) : 86 - 92
  • [10] Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits
    Horikawa, M
    Yasumuro, M
    Kanno, M
    Hanada, K
    Hashiguchi, M
    Ogata, H
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (12) : 1621 - 1628
12345